• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环糊精在体外诱导人红细胞溶血及形态变化。

Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.

作者信息

Irie T, Otagiri M, Sunada M, Uekama K, Ohtani Y, Yamada Y, Sugiyama Y

出版信息

J Pharmacobiodyn. 1982 Sep;5(9):741-4. doi: 10.1248/bpb1978.5.741.

DOI:10.1248/bpb1978.5.741
PMID:7153847
Abstract

Cyclodextrins (CyDs) at higher concentrations were found to cause hemolysis of human erythrocytes in the order of beta- greater than alpha- greater than gamma-CyD in isotonic solution. Biphasic effects of CyDs were observed for the osmotic and heat-induced hemolysis; i.e. the protection at relatively low CyD concentrations and stimulation at higher CyD concentrations. From the scanning electron microscopic observations, CyDs induced shape changes of membrane internalization type on erythrocytes. CyDs caused the release of cholesterol from erythrocyte membrane in the order of beta- greater than gamma- greater than alpha-CyD. These results clearly indicate that CyD-induced hemolysis is probably a secondary event resulting from the membrane disruption which elicited the removal of membrane components from erythrocytes.

摘要

研究发现,在等渗溶液中,浓度较高的环糊精(CyDs)会导致人红细胞溶血,其溶血顺序为β-环糊精>α-环糊精>γ-环糊精。对于渗透压和热诱导的溶血,观察到环糊精具有双相作用;即在相对较低的环糊精浓度下起到保护作用,而在较高浓度下则产生刺激作用。通过扫描电子显微镜观察发现,环糊精会诱导红细胞发生膜内化类型的形状变化。环糊精导致红细胞膜中胆固醇的释放顺序为β-环糊精>γ-环糊精>α-环糊精。这些结果清楚地表明,环糊精诱导的溶血可能是由于膜破坏引发红细胞膜成分去除所导致的继发事件。

相似文献

1
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.环糊精在体外诱导人红细胞溶血及形态变化。
J Pharmacobiodyn. 1982 Sep;5(9):741-4. doi: 10.1248/bpb1978.5.741.
2
Protective effects of cyclodextrins on drug-induced hemolysis in vitro.环糊精对药物诱导的体外溶血的保护作用。
J Pharmacobiodyn. 1981 Feb;4(2):142-4. doi: 10.1248/bpb1978.4.142.
3
Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.环糊精对氯丙嗪诱导的溶血及中枢神经系统反应的影响。
J Pharm Pharmacol. 1981 Nov;33(11):707-10. doi: 10.1111/j.2042-7158.1981.tb13909.x.
4
Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro.β-环糊精对吩噻嗪类抗精神病药物体外诱导溶血的保护机制。
J Pharmacobiodyn. 1983 Jun;6(6):408-14. doi: 10.1248/bpb1978.6.408.
5
Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.3-羟丙基-β-环糊精和2,3-二羟丙基-β-环糊精的一些药学性质及其增溶和稳定能力。
Chem Pharm Bull (Tokyo). 1989 Apr;37(4):1059-63. doi: 10.1248/cpb.37.1059.
6
Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes.α-、β-和γ-环糊精对人红细胞的不同作用。
Eur J Biochem. 1989 Dec 8;186(1-2):17-22. doi: 10.1111/j.1432-1033.1989.tb15171.x.
7
Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.硫酸β-环糊精的包合模式表征及其对氯丙嗪诱导的兔红细胞溶血的影响。
Chem Pharm Bull (Tokyo). 1994 Nov;42(11):2332-7. doi: 10.1248/cpb.42.2332.
8
Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.β-环糊精的硫酸盐和磺丁基醚对体外红细胞膜的不同作用。
Pharm Res. 1995 Jan;12(1):78-84. doi: 10.1023/a:1016238720701.
9
The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids.2-羟丙基-β-环糊精对胆汁酸诱导的溶血作用的影响。
J Pharm Pharmacol. 1996 Jun;48(6):641-4. doi: 10.1111/j.2042-7158.1996.tb05988.x.
10
Effect of 2,6-di-O-methyl-alpha-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells.2,6-二-O-甲基-α-环糊精对兔红细胞溶血及形态变化的影响
Eur J Pharm Sci. 2006 Oct 1;29(2):111-9. doi: 10.1016/j.ejps.2006.06.002. Epub 2006 Jun 10.

引用本文的文献

1
Cyclodextrins as a Strategy for Enhancing Solubility of Therapeutic Agents for Neglected Tropical Diseases: A Systematic Review.环糊精作为提高被忽视热带病治疗药物溶解度的策略:一项系统综述
Curr Med Chem. 2025;32(17):3466-3492. doi: 10.2174/0109298673318410240627031819.
2
Cyclodextrins permeabilize DPPC liposome membranes: a focus on cholesterol content, cyclodextrin type, and concentration.环糊精可使二棕榈酰磷脂酰胆碱脂质体膜通透化:聚焦胆固醇含量、环糊精类型及浓度
Beilstein J Org Chem. 2023 Oct 17;19:1570-1579. doi: 10.3762/bjoc.19.115. eCollection 2023.
3
Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release.
各种环糊精衍生物对神经节苷脂和胆固醇的差异耗竭及其对突触小体谷氨酸释放的影响。
Int J Mol Sci. 2022 Aug 21;23(16):9460. doi: 10.3390/ijms23169460.
4
Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the K1.3 Ion Channel Independent of Membrane Cholesterol Extraction.环糊精对K1.3离子通道发挥类似配体的电流抑制作用,与膜胆固醇提取无关。
Front Mol Biosci. 2021 Nov 4;8:735357. doi: 10.3389/fmolb.2021.735357. eCollection 2021.
5
Direct Measurement of Intermolecular Mechanical Force for Nonspecific Interactions between Small Molecules.小分子非特异性相互作用的分子间机械力的直接测量。
J Phys Chem Lett. 2021 Nov 25;12(46):11316-11322. doi: 10.1021/acs.jpclett.1c03142. Epub 2021 Nov 15.
6
Assessment of the Biocompatibility of Cucurbiturils in Blood Cells.葫芦脲在血细胞中的生物相容性评估。
Nanomaterials (Basel). 2021 May 21;11(6):1356. doi: 10.3390/nano11061356.
7
Cyclodextrins in Antiviral Therapeutics and Vaccines.环糊精在抗病毒治疗与疫苗中的应用
Pharmaceutics. 2021 Mar 19;13(3):409. doi: 10.3390/pharmaceutics13030409.
8
Partial inclusion complex assisted crosslinked β-cyclodextrin nanoparticles for improving therapeutic potential of docetaxel against breast cancer.部分包合复合物辅助交联β-环糊精纳米粒提高多西紫杉醇治疗乳腺癌的潜力。
Drug Deliv Transl Res. 2022 Mar;12(3):562-576. doi: 10.1007/s13346-021-00956-z. Epub 2021 Mar 27.
9
Cyclodextrins: Emerging Medicines of the New Millennium.环糊精:新千年的新兴药物。
Biomolecules. 2019 Nov 28;9(12):801. doi: 10.3390/biom9120801.
10
In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease.乳糖基-β-环糊精作为尼曼-匹克C型病肝肿大治疗剂的体内疗效和安全性评估
Nanomaterials (Basel). 2019 May 25;9(5):802. doi: 10.3390/nano9050802.